LNTH•globenewswire•
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Summary
BEDFORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today reported financial results for its fourth quarter and full year ended December 31, 2025.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 26, 2026 by globenewswire